Growth hormone response to clonidine in anovulatory infertile women resistant to clomiphene citrate stimulation

Fertility and Sterility

Volumn 73, Issue 1, 2000, Pages 78-84

  Rossato, Plinio ^a   Minuto, Francesco ^b   Garrone, Simona ^b   Ragni, Nicola ^b  

^a Ospedale Evangelico Internazionale   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Anovulatory infertility; Clomiphene citrate; Clonidine; GH

Indexed keywords

CLOMIFENE CITRATE; CLONIDINE; GLUCOSE; GROWTH HORMONE; INSULIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN C;

ADULT; ANOVULATION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESISTANCE; FEMALE; GLUCOSE BLOOD LEVEL; GROWTH HORMONE RELEASE; HUMAN; INSULIN BLOOD LEVEL; OVULATION INDUCTION; PRIORITY JOURNAL;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; CLOMIPHENE; CLONIDINE; DRUG RESISTANCE; FEMALE; FERTILITY AGENTS, FEMALE; HUMAN GROWTH HORMONE; HUMANS; INFERTILITY, FEMALE; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR I; OVULATION INDUCTION; PROSPECTIVE STUDIES;

EID: 0033973325     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(99)00456-2     Document Type: Article

References (27)

1. Downs K.A., Gibson M. Clomiphene citrate therapy for luteal phase defect. Fertil Steril. 39:1983;34-38.
2. Hammond M.G. Monitoring technique for improved pregnancy rates during clomiphene ovulation induction. Fertil Steril. 42:1984;499-509.
3. Lobo R.A., Gysler M., March C.M., Goebelsmann M., Mishell D.R. Clinical and laboratory predictors of clomiphene response. Fertil Steril. 37:1982;168-174.
4. Isaacs J.D., Lincoln S.R., Cowan B.D. Extended clomiphene citrate (CC) and prednisone for the treatment of chronic anovulation resistant to CC alone. Fertil Steril. 67:1997;641-643.
5. Barreca A., Artini P.G., Del Monte P., Ponzani P., Pasquini P., Cariola G., et al. In vivo and in vitro effect of growth hormone on estradiol secretion by human granulosa cells. J Clin Endocrinol Metab. 77:1993;61-67.
6. Menashe Y., Lunenfeld B., Pariente C., Frenkel Y., Mashiach S. Can growth hormone increase, after clonidine administration, predict the dose of human menopausal hormone needed for induction of ovulation? Fertil Steril. 53:1990;432-434.
7. Ovesen P., Moller G., Moller N., Christiansen J.S., Orskov J.O.L. Growth hormone secretory capacity and serum insulin-like growth factor I levels in primary infertile, anovulatory women with regular menses. Fertil Steril. 57:1992;97-100.
8. Roozenburg B.J., van Dessel H., Evers J., Bots R. Successful induction of ovulation in normogonadotrophic clomiphene resistant anovulatory women by combined naltrexone and clomiphene citrate treatment. Hum Reprod. 12:1997;1720-1722.
9. Quigley M.M., Berkowitz A.S., Gilbert S.A., Wolf D.P. Clomiphene citrate in an in vitro fertilization program hormonal comparisons between 50- and 150-mg daily dosages . Fertil Steril. 41:1984;809-815.
10. Adashi E. Intraovarian regulation the proposed role of insulin-like growth factors . Ann NY Acad Sci. 697:1993;10-12.
11. Barreca A., Del Monte P., Ponzani P., Artini P.G., Genazzani A.R., Minuto F. Intrafollicular insulin-like growth factor-II levels in normally ovulating women and in patients with polycystic ovary syndrome. Fertil Steril. 65:1996;739-745.
12. Saggese G., Cesaretti G., Giannesi N., Brancaloni C., Cinquanta L., Cioni C. Stimulated growth hormone (GH) secretion in children with delays of pubertal development before and after the onset of puberty relationship with peripheral plasma GH-releasing hormone and somatostatin levels . J Clin Endocrinol Metab. 74:1992;272-278.
13. Magnan E., Catldi M., Guillaume V. Role of growth hormone (GH)-releasing hormone and somatostatin in the mediation of clonidine induced GH release in sheep. Endocrinology. 134:1994;562-567.
14. Lee E.-J., Lee B.S., Lee H.C., Park K.H., Song C.H., Huh K.B. Growth hormone response to L-dopa and pyridostigmine in women with polycystic ovarian syndrome. Fertil Steril. 60:1993;53-57.
15. Yamashita S., Weiss M., Melmed S. Insulin-like growth factor I regulates growth hormone secretion and messenger ribonucleic acid levels in human pituitary tumour cells. J Clin Endocrinol Metab. 63:1986;730-735.
16. Kazer R.R., Unterman T.G., Glick R.P. An abnormality of the growth hormone/insulin-like growth factor-I axis in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 71:1990;958-962.
17. Murakawa H., Hasegawa I., Kurabayashi T., Tanaka K. Polycystic ovary syndrome. Insulin resistance and ovulatory response to clomiphene citrate. J Reprod Med. 44:1999;23-27.
18. Slowinska-Srdeznicka J., Zgliczynsksi W., Wakowska A., Jeske W., Brzezinska A., Soszynski P., et al. An abnormality of the growth hormone/insulin like growth factor-I axis in women with polycystic ovary syndrome due to coexistent obesity. J Clin Endocrinol Metab. 74:1992;1432-1435.
19. Word R.A., Odom M.J., Byrd W., Carr B.R. The effect of gonadotropin-releasing hormone agonists on growth hormone secretion in adult premenopausal women. Fertil Steril. 54:1990;73-78.
20. Ovesen P., Ingerslev H.J., Orskov H., Ledet T. Effect of growth hormone on steroidogenesis, insulin-like growth factor-1 (IGF-1) and IGF-binding protein-1 production and DNA synthesis in cultured human luteinized granulosa cells. J Endocrinol. 140:1994;313-319.
21. Katz E., Ricciarelli E., Adashi E.Y. The potential relevance of growth hormone to female reproductive physiology and pathophysiology. Fertil Steril. 59:1993;8-34.
22. Rosenfeld R.G., Rosenbloom A.L., Guevara-Aguirre J. Growth hormone (GH) insensitivity due to primary GH receptor deficiency. Endocr Rev. 15:1994;369-370.
23. Suikkari A.-M., MacLachlan V., Koistinen R., Seppâlä M., Healy D.L. Double-blind placebo controlled study human biosynthetic growth hormone for assisted reproductive technology . Fertil Steril. 65:1996;800-805.
24. Homburg R., Levy T., Ben-Rafael Z. Adjuvant growth hormone for induction of ovulation with gonadotrophin-releasing hormone agonist and gonadotrophins in polycystic ovary syndrome a randomized double blind placebo controlled trial . Hum Reprod. 10:1995;2550-2553.
25. Blumenfeld Z., Dirnfeld M., Gonen Y., Abramovici H. Growth hormone co-treatment for ovulation induction may enhance conception in the co-treatment and succeeding cycles, in clonidine negative but not clonidine positive patients. Hum Reprod. 9:1994;209-213.
26. Volpe A., Artini P.G., Barreca A., Coukos G., Minuto F., Genazzani A.R. Effects of growth hormone administration in addition to gonadotrophins in normally ovulating women and polycystic ovary syndrome (PCO) patients. Hum Reprod. 7:1992;1347-1352.
27. Genazzani A.D., Petraglia F., Volponi C. Growth hormone treatment affects plasma LH pulsatile release in women with secondary amenorrhoea. Clin Endocrinol (Oxf). 39:1993;607-611.